search
Back to results

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

Primary Purpose

High Risk for Breast Cancer

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Decision aid video
Genetic counseling informational brochure
Sponsored by
University of Illinois at Chicago
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for High Risk for Breast Cancer

Eligibility Criteria

25 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Are female
  2. Identify as African American
  3. Are age 25 or older
  4. Speak and understand English
  5. Completed a cancer genetic risk assessment (CGRA) as part of clinic intake
  6. Are classified as high risk for developing breast cancer per CGRA
  7. Have not previously received genetic counseling

Exclusion Criteria:

  1. Are not female
  2. Do not identify as African American
  3. Are age 24 or younger
  4. Do not speak and understand English
  5. Did not complete a cancer genetic risk assessment (CGRA) as part of clinic intake
  6. Are not classified as high risk for developing breast cancer per CGRA
  7. Have previously received genetic counseling

Sites / Locations

  • UIC Cancer Center
  • University of Illinois at Chicago Hospital and Ambulatory ClinicsRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Decision aid video

Genetic counseling informational brochure

Arm Description

Participants receiving the intervention will complete a pretest, watch the decision aid video, and complete posttest via tablet computer facilitated by Patient Navigators.

Participants receiving the control will complete pretest, review a genetic counseling brochure with the Patient Navigators, and complete posttest via tablet computer facilitated by a Patient Navigator.

Outcomes

Primary Outcome Measures

Genetic Counseling Attendance
Compare the effects of intervention vs. control arm on genetic counseling attendance among African American women recommended for genetic counseling through cancer genetic risk assessment. Assessed via EMR and survey at follow-up. 2-item (Did patient complete genetic counseling appointment? A) Self-report and B) EMR) 1 items assessing familial referral to genetic counseling or testing

Secondary Outcome Measures

Decision Aid Usability
5-item agreement likert scale to assess usability, satisfaction, decisional conflict (e.g., I felt I could relate to what the actors were saying?) Assessed via survey at immediate posttest
Knowledge about Genetic Counseling
Items to assess changes in knowledge about genetic counseling for breast cancer risk between pre and post intervention; (e.g., A purpose of genetic counseling is to help people understand their options for genetic testing.) Relevant items from published instrument (Maio) and Facing Our Risk of Cancer Empowerment (FORCE) brochure (control arm brochure) adapted for genetic counseling for breast cancer. Assessed via survey at pretest and posttest.
Distress Associated with Genetic Counseling and Breast Cancer Risk
Items to assess patient worry/anxiety related to genetic counseling and breast cancer risk; (e.g., How often have you thought about your chances of getting cancer?) 7-item Cancer Worry Scale Assessed via survey at pretest and posttest.
Intrinsic Motivation for Genetic Counseling Attendance
Items to assess motivation for genetic counseling attendance (e.g., The reason I would attend genetic counseling is because I feel that I want to take responsibility for my own health.) 15-item Treatment Self-Regulation Questionnaire and 4-item Self-Efficacy Scale Assessed via survey at pretest and posttest.
Risk Perception Associated with Breast Cancer
Items to assess perception of risk related to getting breast cancer (In your opinion, compared to other women your age, what are your chances of getting breast cancer?) 1-item question obtained from published instrument. Assessed via survey at pretest and posttest.
Diffusion of Knowledge
Items to assess sharing of knowledge among social and familial networks about genetic counseling. Diffusion of knowledge will be assessed by collecting data on social network size, composition, density, and information sharing related to genetic counseling and risks. Relevant social network assessment items-General Social Survey. Examples: Name generator: (From time to time, most people discuss important matters with other people. Looking back over the past month, who are the people with whom you discussed genetic counseling or genetic risks? Name interpreter: (e.g., What is relationship between you and X?) Assessed at 4 week follow-up

Full Information

First Posted
May 1, 2020
Last Updated
September 19, 2023
Sponsor
University of Illinois at Chicago
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04378751
Brief Title
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer
Official Title
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 6, 2023 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Chicago
Collaborators
National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the United States, carriers of hereditary genetic mutations have up to an 85% risk of developing breast cancer compared to 12% in the general population. Overall uptake of genetic services is generally low, particularly among high-risk African American (AA) women, who carry a disproportionate burden of breast cancer mortality. Further, although testing close relatives of individuals who test positive for a pathogenic variant might curtail breast cancer disparities attributable to hereditary risk, it is unclear how counseled or tested individuals influence their social and familial networks. Using a randomized control trial design, the objective of this research project is to test the effectiveness of a culturally targeted video, previously developed by our research team, on promoting genetic counseling attendance among AA women determined to be at high risk for breast cancer through cancer genetic risk assessment in a clinical setting. This study will also test how psychosocial factors (knowledge, intrinsic motivation, risk perception, and distress) impact the relationships between intervention exposures (video versus brochure) and compare the impact of intervention exposures on diffusion of knowledge about genetic counseling through social network analysis.
Detailed Description
Study Design. The investigator will conduct a randomized control trial single-blind control trial to test the effectiveness of a culturally targeted decision aid video to promote genetic counseling among African American determined to be high risk for breast cancer through cancer genetic risk assessment. Eligible patients will be randomly assigned to receive information about genetic counseling using a culturally targeted decision aid video (treatment group) or a brochure (control). Research Protocol. As part of standard of care, patients will complete a cancer genetic risk assessment (CGRA) as part of intake on a tablet computer provided by the front desk clinic staff. CGRA results will be uploaded to the EMR, printed and given to a patient navigator. The patient navigator will approach patients, give them a recruitment flyer, information about the study, screen patients and obtain informed consent for women who choose to participate in the study. Based on computer-generated randomization (equal numbers in each arm), patients will be randomized to one of two groups to receive: 1) pretest, view decision aid video, and posttest or 2) pretest, genetic counseling brochure, and posttest. Both arms will be facilitated by patient navigators. Upon completion of posttest, patient navigators will ask women if they would like to make an appointment for genetic counseling, contact the provider for the order if not already in the EMR, make genetic counseling appointments for women who choose to attend, and monitor and collect follow-up data. All enrolled participants will receive a phone call at 4 weeks post-intervention to (a) verify counseling attendance through self-report and EMR extraction if applicable; (b) ask whether the patient was referred to genetic testing after her genetic counseling if applicable; and (c) ask whether other family members were referred to genetic services if applicable and (d) determine who in their social networks, if anyone, the participant told about genetic counseling, and if so, how this information was shared.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High Risk for Breast Cancer

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Computer-generated randomization (equal numbers in each arm), patients will be randomized to one of two arms: Decision aid video Genetic counseling informational brochure
Masking
Participant
Allocation
Randomized
Enrollment
106 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Decision aid video
Arm Type
Experimental
Arm Description
Participants receiving the intervention will complete a pretest, watch the decision aid video, and complete posttest via tablet computer facilitated by Patient Navigators.
Arm Title
Genetic counseling informational brochure
Arm Type
Active Comparator
Arm Description
Participants receiving the control will complete pretest, review a genetic counseling brochure with the Patient Navigators, and complete posttest via tablet computer facilitated by a Patient Navigator.
Intervention Type
Behavioral
Intervention Name(s)
Decision aid video
Intervention Description
Decision aid video
Intervention Type
Behavioral
Intervention Name(s)
Genetic counseling informational brochure
Intervention Description
Genetic counseling informational brochure
Primary Outcome Measure Information:
Title
Genetic Counseling Attendance
Description
Compare the effects of intervention vs. control arm on genetic counseling attendance among African American women recommended for genetic counseling through cancer genetic risk assessment. Assessed via EMR and survey at follow-up. 2-item (Did patient complete genetic counseling appointment? A) Self-report and B) EMR) 1 items assessing familial referral to genetic counseling or testing
Time Frame
52 weeks
Secondary Outcome Measure Information:
Title
Decision Aid Usability
Description
5-item agreement likert scale to assess usability, satisfaction, decisional conflict (e.g., I felt I could relate to what the actors were saying?) Assessed via survey at immediate posttest
Time Frame
52 weeks
Title
Knowledge about Genetic Counseling
Description
Items to assess changes in knowledge about genetic counseling for breast cancer risk between pre and post intervention; (e.g., A purpose of genetic counseling is to help people understand their options for genetic testing.) Relevant items from published instrument (Maio) and Facing Our Risk of Cancer Empowerment (FORCE) brochure (control arm brochure) adapted for genetic counseling for breast cancer. Assessed via survey at pretest and posttest.
Time Frame
52 weeks
Title
Distress Associated with Genetic Counseling and Breast Cancer Risk
Description
Items to assess patient worry/anxiety related to genetic counseling and breast cancer risk; (e.g., How often have you thought about your chances of getting cancer?) 7-item Cancer Worry Scale Assessed via survey at pretest and posttest.
Time Frame
52 weeks
Title
Intrinsic Motivation for Genetic Counseling Attendance
Description
Items to assess motivation for genetic counseling attendance (e.g., The reason I would attend genetic counseling is because I feel that I want to take responsibility for my own health.) 15-item Treatment Self-Regulation Questionnaire and 4-item Self-Efficacy Scale Assessed via survey at pretest and posttest.
Time Frame
52 weeks
Title
Risk Perception Associated with Breast Cancer
Description
Items to assess perception of risk related to getting breast cancer (In your opinion, compared to other women your age, what are your chances of getting breast cancer?) 1-item question obtained from published instrument. Assessed via survey at pretest and posttest.
Time Frame
52 weeks
Title
Diffusion of Knowledge
Description
Items to assess sharing of knowledge among social and familial networks about genetic counseling. Diffusion of knowledge will be assessed by collecting data on social network size, composition, density, and information sharing related to genetic counseling and risks. Relevant social network assessment items-General Social Survey. Examples: Name generator: (From time to time, most people discuss important matters with other people. Looking back over the past month, who are the people with whom you discussed genetic counseling or genetic risks? Name interpreter: (e.g., What is relationship between you and X?) Assessed at 4 week follow-up
Time Frame
56 weeks

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Are female Identify as African American Are age 25 or older Speak and understand English Completed a cancer genetic risk assessment (CGRA) as part of clinic intake Are classified as high risk for developing breast cancer per CGRA Have not previously received genetic counseling Exclusion Criteria: Are not female Do not identify as African American Are age 24 or younger Do not speak and understand English Did not complete a cancer genetic risk assessment (CGRA) as part of clinic intake Are not classified as high risk for developing breast cancer per CGRA Have previously received genetic counseling
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kent Hoskins, MD
Phone
312-355-0496
Email
khoski@uic.ed
First Name & Middle Initial & Last Name or Official Title & Degree
Erica Seltzer, DrPH
Phone
312- 413-7432
Email
eseltzer@uic.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kent Hoskins, MD
Organizational Affiliation
University of Illinois at Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
UIC Cancer Center
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vida Henerson, PhD
Phone
312-413-7455
Email
vahender@fredhutch.org
First Name & Middle Initial & Last Name & Degree
Erica Seltzer, DrPH
Phone
312-413-7432
Email
eseltzer@uic.edu
Facility Name
University of Illinois at Chicago Hospital and Ambulatory Clinics
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vida Henderson, PhD
Phone
312-413-7455
Email
vahender@fredhutch.org
First Name & Middle Initial & Last Name & Degree
Erica I Seltzer, DrPH
Phone
312-413-7432
Email
eseltzer@uic.edu

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer

We'll reach out to this number within 24 hrs